Search

Search Results
Results 4661 - 4670 of 5011 for Movement Disorder
  • Drug - 15 Nov 2022
    Consumer Medicine Information (CMI) about Osteovan (Zoledronic acid) intended for persons living in Australia.
  • News - 1 Apr 2020
    From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and...
  • Health - 26 Feb 2019
    Huntington’s disease is an incurable genetic disorder that is inherited in an autosomal dominant manner. A diagnosis of Huntington’s disease can be very distressing for a patient and their family to...
  • Health - 26 Feb 2019
    Epstein-Barr virus (EBV) is a herpes virus otherwise known of as human herpesvirus 4 (HHV-4). It is most well known for causing glandular fever but research shows that EBV infection is also linked to...
  • Drug - 21 Jan 2026
    Consumer Medicine Information (CMI) about Remicade intended for persons living in Australia.
  • Drug - 19 Jan 2026
    Consumer Medicine Information (CMI) about Symtuza intended for persons living in Australia.
  • Health - 8 Jan 2026
    Dry January is a global alcohol abstinence challenge associated with metabolic, cardiovascular, and mental health benefits.
  • Health - 1 Jan 2026
    How simple, evidence-based morning habits recalibrate the circadian system to sharpen cognition, stabilize mood, and support long-term mental health.
  • Drug - 16 Dec 2025
    Consumer Medicine Information (CMI) about DBL Dexamethasone Sodium Phosphate intended for persons living in Australia.
  • Drug - 15 Dec 2025
    Consumer Medicine Information (CMI) about Actrapid, Protaphane, Mixtard 30/70 intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.